Jeff Jones
Company: Cullinan Therapeutics
Job title: Chief Medical Officer
Seminars:
Looking into the Differences in Approaching TCEs for Autoimmune vs Oncology Indications 1:00 pm
Comparing the mechanistic and translational differences in T-cell engager design for autoimmune diseases versus oncology, including target selection and immune activation thresholds Evaluating safety considerations, balancing immune activation and toxicity, and lessons learned from cytokine release syndrome management in both therapeutic areas Exploring emerging strategies to tailor T-cell engagers for autoimmune indications, including selective T-cell…Read more
day: Day 1